New Avita Medical Seeking Alpha Analysis by WST, page-15

I have trouble getting my head around the dual listing of this company....Australia and United States. This helped me...a bit!

"Avita Medical is a biotechnology company that has a dual listing on the Australian Securities Exchange (ASX) and the NASDAQ stock market in the United States. This means that the company has issued shares that trade on both markets, under the ticker symbols AVH and RCEL respectively.

A dual listing allows the company to access a larger pool of investors, capital, and liquidity, as well as increase its global exposure and recognition.A dual listing is different from a cross listing, where a company lists its shares on a foreign market in addition to its home market, but does not issue new shares. A dual listing is also different from a secondary listing, where a company lists its shares on another market, but maintains its primary listing and regulatory compliance in its home market2.Avita Medical completed its dual listing on the NASDAQ on 1 July 2020, after raising US$69.1 million from a prospectus offer. The company also implemented a 100-for-1 share consolidation to reduce the number of shares on issue and align its share price with the US market.Note: For more information about Avita Medical and its dual listing, you can visit its official website or read its latest quarterly report."